Gufic Biosciences rose 1.44% to Rs 70.40 at 10:45 IST on BSE after net profit rose 38.12% to Rs 3.54 crore on 7.77% rise in total income to Rs 64.5 crore in Q1 June 2017 over Q1 June 2016.
The result was announced after market hours yesterday, 14 September 2017.Meanwhile, the S&P BSE Sensex was down 47.79 points, or 0.15% at 32,194.14. The S&P BSE Small-Cap index was down 29.48 points, or 0.18% at 16,595.82.
On the BSE, 32,782 shares were traded on the counter so far as against the average daily volume of 33,804 shares in the past one quarter. The stock had hit a high of Rs 73 and a low of Rs 69.40 so far during the day. The stock had hit a record high of Rs 79.55 on 20 July 2017 and hit a 52-week low of Rs 33.30 on 29 September 2016.
The small-cap company has equity capital of Rs 7.74 crore. Face value per share is Rs 1.
Gufic Biosciences is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)